AIM Stock Analysis: Buy, Sell, or Hold?
AIM - AIM ImmunoTech Inc.
$0.28
-0.02 (-5.41%)
▼
5d:
-21.22%
30d:
-66.13%
90d:
-49.09%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When AIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AIM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AIM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AIM is currently trading at $0.28, which is considered slightly low relative to its 30-day fair value range of $0.28 to $0.59.
Technical Outlook: Technically, AIM is in a strong downtrend. Immediate support is located at $0.26, while resistance sits at $0.40. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: AIM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.25 (+1775.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AIM is in a strong downtrend. Immediate support is located at $0.26, while resistance sits at $0.40. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: AIM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.25 (+1775.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.28 -
$0.59
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.4%)
- BULLISH: Trading 1775.0% below Wall St target ($5.25)
- CAUTION: 5-day price weakness (-21.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.28 -
$0.59
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.26
Resistance Level
$0.40
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.54
Wall Street Target
$5.25
(+1775.0%)
Revenue Growth (YoY)
37.5%
Share & Embed Analysis
Last updated: July 06, 2026 3:56 AM ET
Data refreshes hourly during market hours. Next update: 4:56 AM
Data refreshes hourly during market hours. Next update: 4:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AIM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 61 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$36 | 67 BUY |
